Alvaro H Borges
Overview
Explore the profile of Alvaro H Borges including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
799
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borges A, Russell M, Tait D, Scriba T, Nemes E, Skallerup P, et al.
Lancet Infect Dis
. 2025 Mar;
PMID: 40056922
Background: People with tuberculosis who complete treatment remain at risk of recurrent disease. The vaccine H56:IC31 has been shown to be safe and immunogenic in phase 1 and 2 studies,...
2.
Pollock K, Borges A, Cheeseman H, Rosenkrands I, Schmidt K, Sondergaard R, et al.
Lancet Infect Dis
. 2024 Apr;
24(8):829-844.
PMID: 38615673
Background: There is no vaccine against the major global pathogen Chlamydia trachomatis; its different serovars cause trachoma in the eye or chlamydia in the genital tract. We did a clinical...
3.
Tait D, Diacon A, Borges A, van Brakel E, Hokey D, Rutkowski K, et al.
J Infect Dis
. 2024 Apr;
230(5):1262-1270.
PMID: 38557639
Background: H56:IC31 is a candidate vaccine against tuberculosis (TB) with the potential to reduce TB recurrence rate. It is thus important for future clinical trials to demonstrate safety and immunogenicity...
4.
Rasmussen D, Moller D, Hamm S, Borges A, Nielsen A, Kirkby N, et al.
Microorganisms
. 2024 Jan;
12(1).
PMID: 38257892
Infection with BK polyomavirus (BKPyV) is a common opportunistic infection after kidney transplantation (KT) and may affect graft function. We aimed to determine the incidence, risk factors, and clinical outcomes...
5.
Chammartin F, Mocroft A, Egle A, Zangerle R, Smith C, Mussini C, et al.
Clin Infect Dis
. 2023 Dec;
78(4):995-1004.
PMID: 38092042
Background: Human immunodeficiency virus (HIV) infection leads to chronic immune activation/inflammation that can persist in virally suppressed persons on fully active antiretroviral therapy (ART) and increase risk of malignancies. The...
6.
Knudsen A, Eskelund C, Benfield T, Zhao Y, Gelpi M, Kober L, et al.
AIDS
. 2023 Nov;
38(4):487-495.
PMID: 37976039
Background: Clonal hematopoiesis of indeterminate potential (CHIP) has been associated with older age, inflammation and with risk of coronary artery disease (CAD). We aimed to characterize the burden of CHIP,...
7.
Imbratta C, Gela A, Bilek N, Mabwe S, Cloete Y, Mortensen R, et al.
Cytometry A
. 2023 Sep;
103(12):992-1003.
PMID: 37675607
We developed a flow cytometry-based assay, termed Differential Leukocyte Counting and Immunophenotyping in Cryopreserved Ex vivo whole blood (DLC-ICE), that allows quantification of absolute counts and frequencies of leukocyte subsets...
8.
Thudium R, Arentoft N, Hoel H, Afzal S, von Stemann J, Forman J, et al.
J Infect Dis
. 2023 Jun;
228(8):1080-1088.
PMID: 37366576
Background: People with human immunodeficiency virus (PWH) have an increased risk of chronic lung diseases and chronic inflammation. We aimed to investigate if inflammatory markers and monocyte activation are associated...
9.
Reilly C, Borges A, Baker J, Safo S, Sharma S, Polizzotto M, et al.
J Infect Dis
. 2022 Dec;
227(8):951-960.
PMID: 36580481
Background: There is an incompletely understood increased risk for cardiovascular disease (CVD) among people with HIV (PWH). We investigated if a collection of biomarkers were associated with CVD among PWH....
10.
Murray D, Grund B, MacPherson C, Ekenberg C, Zucco A, Reekie J, et al.
AIDS
. 2022 Dec;
37(3):379-387.
PMID: 36473831
Introduction: Identifying genetic factors that influence HIV-pathogenesis is critical for understanding disease pathways. Previous studies have suggested a role for the human gene ten-eleven methylcytosine dioxygenase 2 (TET2) in modulating...